(NASDAQ:SNPS), NEW YORK, Nov. 14, 2025 (GLOBE NEWSWIRE) — Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the “Class”) who purchased or acquired the securities of Synopsys, Inc. (“Synopsys” or the “Company”) (NASDAQ: SNPS) between December 4, 2024 and September 9, 2025, inclusive. Should You […]

SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Synopsys, Inc. (NASDAQ: SNPS) GlobeNewswire November 14, 2025 NEW YORK, Nov. 14, 2025 (GLOBE NEWSWIRE) — Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the “Class”) who purchased or

Seven in 10 Americans say raising children is now unaffordable; many express deep ambivalence about digital innovation American families face an unprecedented convergence of challenges in 2025, with economic affordability emerging as the dominant challenge affecting family formation and size, according to the eleventh annual American Family Survey released today. Americans also continue to grapple

BELLEVUE, Wash., Nov. 14, 2025 (GLOBE NEWSWIRE) — Truveta's analysis of early measles, mumps, and rubella (MMR) vaccinations among Texas infants published today in JAMA Network Open. The study reveals a sharp increase in early MMR vaccinations among infants in Texas during the state's 2025 measles outbreak, aligning closely with public health recommendations and demonstrating

(NasdaqGM:CYTK),(NYSE:NX),(NYSE:FCX),(NYSE:PRMB), NEW YORK, Nov. 14, 2025 (GLOBE NEWSWIRE) — Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Cytokinetics, Incorporated (NASDAQ:CYTK), Quanex Building Products Corporation (NYSE:NX), Freeport-McMoran Inc. (NYSE:FCX), and Primo Brands Corporation (NYSE:PRMB). Stockholders have until the deadlines

(NYSE:KMX), LOS ANGELES, Nov. 14, 2025 (GLOBE NEWSWIRE) — The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against CarMax, Inc. (“CarMax” or “the Company”) (NYSE: KMX) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the

KMX Investors Have Opportunity to Lead CarMax, Inc. Securities Fraud Lawsuit with the Schall Law Firm GlobeNewswire November 14, 2025 LOS ANGELES, Nov. 14, 2025 (GLOBE NEWSWIRE) — The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against CarMax, Inc. (“CarMax” or “the Company”) (NYSE: KMX) for

Truveta research published in JAMA Network Open shows rapid uptake of early measles vaccination during Texas outbreak New research published in JAMA Network Open led by Truveta Research GlobeNewswire November 14, 2025 BELLEVUE, Wash., Nov. 14, 2025 (GLOBE NEWSWIRE) — Truveta's analysis of early measles, mumps, and rubella (MMR) vaccinations among Texas infants published today

Bragar Eagel & Squire, P.C. Urgently Reminds Investors of Cytokinetics, Quanex, Freeport, and Primo Brands to Contact the Firm About their Rights GlobeNewswire November 14, 2025 NEW YORK, Nov. 14, 2025 (GLOBE NEWSWIRE) — Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on

NEW YORK, NY / ACCESS Newswire / November 14, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Akebia Therapeutics, Inc. ("Akebia Therapeutics, Inc.") (NASDAQ:AKBA) concerning possible violations of federal securities laws. On October 29, 2025, Akebia announced that it will not pursue the VALOR trial for Vafseo label expansion